[ Price : $8.95]
FDA finalizes a guidance outlining how generic drug developers should evaluate the adhesion performance of transdermal and topical...[ Price : $8.95]
Novo Nordisk says its investigational anti-inflammatory drug ziltivekimab failed to reduce the risk of major adverse cardiovascula...[ Price : $8.95]
FDA issues a revised draft guidance updating its recommendations for how generic drug developers should evaluate the skin irritati...[ Price : $8.95]
FDA approves Novartis' Pluvicto (lutetium Lu 177 vipivotide tetraxetan) in combination with androgen receptor pathway inhibitor (A...[ Price : $8.95]
Sen. Ron Johnson asks to interview four former CBER officials and Anthony Fauci on the safety and efficacy of Covid vaccines.[ Price : $8.95]
FDA accepts for priority review a Johnson & Johnson supplemental BLA for subcutaneous Rybrevant Faspro for adults with recurrent o...[ Price : $8.95]
FDA cites contract drug manufacturer Cerovene Inc. for repeat current good manufacturing practice deficiencies following a recent ...[ Price : $8.95]
A Friends of Cancer Research survey report documents bottlenecks in U.S. oncology clinical trial site scale-up activation and sugg...